CVE-2023-38956
ZKTeco
- Published
- 3 August 2023
- Last modified
- 9 July 2026
- CVSS
- 7.5 v3.1
- Severity
- high
- EPSS
- 0.7% (52th pct)
- CISA KEV
- Not listed
- NVD status
- Modified
- Weaknesses
- CWE-22
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Description
A path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files via supplying a crafted payload.
Exploitation
Not listed in the CISA Known Exploited Vulnerabilities catalogue as of 2026.09.04. That is an absence of confirmed public exploitation, not evidence that exploitation has not occurred. EPSS models a 0.7% probability of exploitation activity in the next 30 days.
Affected products
| Product | Vendor | Type | Versions named |
|---|---|---|---|
| Bioaccess Ivs | ZKTeco | unknown | 3.3.1 |
References
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38956 third-party
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38956 third-party
Record assembled from NVD, CISA KEV 2026.09.04 and FIRST EPSS 2026-09-04. Affected products are those NVD's CPE configuration names that fall inside this site's scope; a CVE may affect products outside it.